Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor

Clinical trial NCT03041181 · TERMINATED

Trial details

NCT number: NCT03041181
Sponsor: Nasser Hanna, M.D.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Adenocarcinoma of the Lung Lung Cancer Squamous Cell Lung Cancer

Start date: 2017-01-27
Primary completion: 2019-05-23
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.